Literature DB >> 7789014

Wolman disease and its treatment.

M Wolman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7789014     DOI： 10.1177/000992289503400406

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  9 in total

1.  δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.

Authors:  Miao Xu; Ke Liu; Manju Swaroop; Forbes D Porter; Rohini Sidhu; Sally Firnkes; Sally Finkes; Daniel S Ory; Juan J Marugan; Jingbo Xiao; Noel Southall; William J Pavan; Cristin Davidson; Steven U Walkley; Alan T Remaley; Ulrich Baxa; Wei Sun; John C McKew; Christopher P Austin; Wei Zheng
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

2.  Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.

Authors:  Stuart A Scott; Benny Liu; Irina Nazarenko; Suparna Martis; Julia Kozlitina; Yao Yang; Charina Ramirez; Yumi Kasai; Tommy Hyatt; Inga Peter; Robert J Desnick
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

3.  Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors.

Authors:  Anton I Rosenbaum; Madalina Rujoi; Amy Y Huang; Hong Du; Gregory A Grabowski; Frederick R Maxfield
Journal:  Biochim Biophys Acta       Date:  2009-08-20

Review 4.  Lysosome: regulator of lipid degradation pathways.

Authors:  Carmine Settembre; Andrea Ballabio
Journal:  Trends Cell Biol       Date:  2014-07-21       Impact factor: 20.808

5.  Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?

Authors:  Fahd O Ismael; Tessa J Barrett; Diba Sheipouri; Bronwyn E Brown; Michael J Davies; Clare L Hawkins
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

Review 6.  Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.

Authors:  Francis Aguisanda; Natasha Thorne; Wei Zheng
Journal:  Curr Chem Genom Transl Med       Date:  2017-01-30

Review 7.  Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?

Authors:  Francesco Baratta; Daniele Pastori; Domenico Ferro; Giovanna Carluccio; Giulia Tozzi; Francesco Angelico; Francesco Violi; Maria Del Ben
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

8.  "Why them, why me, why us?" The experiences of parents of children with lysosomal acid lipase deficiency: an interpretative phenomenological analysis study.

Authors:  S Hassall; D M Smith; S Rust; S A Jones; A Wittkowski
Journal:  Orphanet J Rare Dis       Date:  2022-05-12       Impact factor: 4.303

9.  Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants.

Authors:  Simon A Jones; Vassili Valayannopoulos; Eugene Schneider; Stephen Eckert; Maryam Banikazemi; Martin Bialer; Stephen Cederbaum; Alicia Chan; Anil Dhawan; Maja Di Rocco; Jennifer Domm; Gregory M Enns; David Finegold; J Jay Gargus; Ornella Guardamagna; Christian Hendriksz; Iman G Mahmoud; Julian Raiman; Laila A Selim; Chester B Whitley; Osama Zaki; Anthony G Quinn
Journal:  Genet Med       Date:  2015-08-27       Impact factor: 8.822
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.